The ratio of C-reactive protein to lymphocytes (CLR) plays a key role in the prognosis of tumors, pancreatic cancer, colorectal cancer, and other related diseases, but there is no study on patients with aSAH. This evidence concerns the gene CRP and familial pancreatic carcinoma.